MBI vs VRTX · rev $51.0M vs P/E 30, rev $3.33B
MBIA Inc (MBI) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
MBIA Inc (MBI) is a insurance - specialty company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported MBI revenue for 2026-06-30 was $51.0M. Net income was -$85.0M. MBI currently screens at market cap $321.4M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
MBI currently screens at market cap $321.4M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the MBI and VRTX stock pages for the full models.
Not investment advice.